- Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Novartis’ migraine medicine trial meets endpoints

Aimovig is designed to target the CGRP receptor associated with migraine. Credit: Christina Victoria Craft on Unsplash.